Most patients with heterozygous SLC2A1 mutations exhibit GLUT1-deficiency syndrome characterized by low CSF-to-blood glucose ratios together with epilepsy, developmental delay, microcephaly, ataxia, and PxD [14]. Here, SLC2A1 is linked to Global developmental delay.